Click a link below to view the mailing archive as if it had been sent to you.
| 2012-05-31 12:00 | | Teva Begins Trading on the New York Stock Exchange and more... |
| 2012-05-31 00:00 | | Buy This Pharma Giant Now For A 30% Return In 2013 and more... |
| 2012-05-30 12:00 | | Start-Up Launches DNA Sequencing-Based Test For Picking Cancer Drugs and more... |
| 2012-05-30 00:00 | | The House PDUFA Bill Would Do What? and more... |
| 2012-05-29 12:00 | | [video] NPS Pharma CEO: Market Recognizing Pipeline Potential and more... |
| 2012-05-28 12:00 | | Arena is Hands Down a Better Investment than Vivus and more... |
| 2012-05-26 00:00 | | FDA Panel Sends Mixed Message About Pfizer Drug and more... |
| 2012-05-25 12:00 | | Johnson & Johnson Could Slip 5% On Lower Margins and more... |
| 2012-05-25 00:00 | | As The Senate Vote On PDUFA Finally NearsâÔö£é?öé??Ôö£éÔö¼?¬ and more... |
| 2012-05-24 12:00 | | Shanghai Pharma Denies Probe Report, Says Deals Complied and more... |
| 2012-05-24 00:00 | | MediciNova asthma drug fails trial; shares crash and more... |
| 2012-05-23 12:00 | | Bill introduced to curb practices of "gray marketers" price-gouging on short-supply medicines and more... |
| 2012-05-23 00:00 | | 22 Biopharma Stocks With Breakout Potential in 2012 |
| 2012-05-22 12:00 | | Merck CEO: Generics, economy to make 2012-13 tough and more... |
| 2012-05-22 00:00 | | Achillion jumps on hepatitis C study and more... |
| 2012-05-21 00:00 | | Sucampo Pharmaceuticals, Inc. : Sucampo Presents Data for AMITIZA?ë?£Ôö£éÔö¼?½ in the Treatment of Moderate to Very Severe Irritabl... and more... |
| 2012-05-20 00:00 | | Noteworthy Insider Buys Last Week In 2 Beaten Down Biotechs, With 4 Other Buys And Sells and more... |
| 2012-05-19 00:00 | | Amarin: May 16 Patent Updates - What Do They Mean? and more... |
| 2012-05-18 12:00 | | Rexahn Pharmaceuticals: Update On Cancer Drugs and more... |
| 2012-05-17 12:00 | | ASCO '12 Abstract Dump: Cancer Stocks in Focus and more... |
| 2012-05-17 00:00 | | Abbott Helps Big Pharma Look Even Worse and more... |
| 2012-05-16 12:00 | | India's Piramal to buy US healthcare company and more... |
| 2012-05-16 00:00 | | Lpath Back In Play and more... |
| 2012-05-15 12:00 | | Furiex says J&J returns sexual dysfunction drug rights and more... |
| 2012-05-14 12:00 | | Pozen Shares On The Rebound Since European Migraine Licensing Deal and more... |
| 2012-05-14 00:00 | | 6 Mid-Cap Biotechnology Stocks With Great Liquidity And Rated Buy Or Better and more... |
| 2012-05-13 12:00 | | 'India has potential to be global hub of bio-pharma sector' and more... |
| 2012-05-13 00:00 | | Drug Approval! Oh, Wait, We Knew That Already. and more... |
| 2012-05-12 00:00 | | Watson Has Double-Digit Upside, But Peers Are 'Strong Buys' and more... |
| 2012-05-11 12:00 | | More drug companies to pay billions for fraud, join the "dishonor roll" after Abbott settlement and more... |
| 2012-05-11 00:00 | | MannKind Narrows Loss and more... |
| 2012-05-10 12:00 | | Novartis to investigate alleged approval irregularities in India, Reuters says and more... |
| 2012-05-10 00:00 | | Senate Probes Drugmakers Over Painkillers and more... |
| 2012-05-09 12:00 | | GileadâÔö£é?öé??Ôö£é?ö?ñós Quad Pill Raises Kidney Questions, FDA Says and more... |
| 2012-05-09 00:00 | | Can Dendreon's New Management Turn Things Around? and more... |
| 2012-05-08 12:00 | | Talon Drops on FDA Review of Cancer Therapy and more... |
| 2012-05-08 00:00 | | 6 Best Biotech Stocks With More Upside Potential and more... |
| 2012-05-07 12:00 | | Eli Lilly's Valuation May Prove To Be A Good Investment Opportunity and more... |
| 2012-05-07 00:00 | | Rolling Gilead Protected Covered Call For Additional Potential Profit and more... |
| 2012-05-06 00:00 | | Bayer appeals India patent office ruling and more... |
| 2012-05-05 00:00 | | Is The Novavax 'New Paradigm' Worth A Second Look? and more... |
| 2012-05-04 12:00 | | Preview: U.S. panel seen backing Pfizer's arthritis drug hope and more... |
| 2012-05-04 00:00 | | Will the FDA Approve Alexza's Adasuve? and more... |
| 2012-05-03 12:00 | | 3 High-Growth Biotech Stocks With Bearish Short Trends and more... |
| 2012-05-03 00:00 | | Allergan profit up 45% on specialty drug sales and more... |
| 2012-05-02 12:00 | | Drug and device trials vary in size, quality: study and more... |
| 2012-05-02 00:00 | | Juicy Details From Tang Capital's Lawsuit Against Savient Pharma and more... |
| 2012-05-01 12:00 | | ViroPharma Incorporated Reports First Quarter 2012 Financial Results and more... |
| 2012-05-01 00:00 | | Pfizer, Gilead Sciences, Arena Pharmaceuticals Face Big Dates in May and more... |
